133 related articles for article (PubMed ID: 38251842)
1. Lymphocyte subpopulations: a potential predictor of a response in patients with immune thrombocytopenia.
Žibřidová K; Souček O; Krčmová LK; Jankovičová K; Gančarčíková M; Pejková MA; Drugda J; Nováková D; Košťál M
Hematology; 2024 Dec; 29(1):2304486. PubMed ID: 38251842
[TBL] [Abstract][Full Text] [Related]
2. The Levels of T Lymphocyte Subsets in Immune Thrombocytopenia Associated with Anti-GPIIb/IIIa- and/or Anti-GPIbα-Mediated Responses Are Differentially Sensitive to Dexamethasone.
Chen Y; Xie Y; Ruan M; Shi J
Acta Haematol; 2018; 140(1):60-66. PubMed ID: 30130794
[TBL] [Abstract][Full Text] [Related]
3. CD8+ T cells are predominantly protective and required for effective steroid therapy in murine models of immune thrombocytopenia.
Ma L; Simpson E; Li J; Xuan M; Xu M; Baker L; Shi Y; Yougbaré I; Wang X; Zhu G; Chen P; Prud'homme GJ; Lazarus AH; Freedman J; Ni H
Blood; 2015 Jul; 126(2):247-56. PubMed ID: 26036802
[TBL] [Abstract][Full Text] [Related]
4. T cell-mediated autoimmunity in immune thrombocytopenia.
Vrbensky JR; Nazy I; Clare R; Larché M; Arnold DM
Eur J Haematol; 2022 Jan; 108(1):18-27. PubMed ID: 34487584
[TBL] [Abstract][Full Text] [Related]
5. Immunological characteristics and effect of cyclosporin in patients with immune thrombocytopenia.
Wang T; He X; Ran N; Liu C; Xing L; Wang H; Fu R; Shao Z
J Clin Lab Anal; 2021 Sep; 35(9):e23922. PubMed ID: 34329516
[TBL] [Abstract][Full Text] [Related]
6. Contributions of T lymphocyte abnormalities to therapeutic outcomes in newly diagnosed patients with immune thrombocytopenia.
Zhao Z; Yang L; Yang G; Zhuang Y; Qian X; Zhou X; Xiao D; Shen Y
PLoS One; 2015; 10(5):e0126601. PubMed ID: 25978334
[TBL] [Abstract][Full Text] [Related]
7. [Recent progress in immune thrombocytopenia pathophysiology and treatment].
Kato H
Rinsho Ketsueki; 2023; 64(9):1106-1115. PubMed ID: 37899189
[TBL] [Abstract][Full Text] [Related]
8. Increased Expressions of OX40 and OX40 Ligand in Patients with Primary Immune Thrombocytopenia.
Cui D; Lv Y; Yuan X; Ruan G; Zhang Y; Yan C; Xu D; Lv M; Mao Y; Cao J; Jin J; Xie J
J Immunol Res; 2019; 2019():6804806. PubMed ID: 30944836
[TBL] [Abstract][Full Text] [Related]
9. Autoimmune thrombocytopenia: flow cytometric determination of platelet-associated CD154/CD40L and CD40 on peripheral blood T and B lymphocytes.
Meabed MH; Taha GM; Mohamed SO; El-Hadidy KS
Hematology; 2007 Aug; 12(4):301-7. PubMed ID: 17654056
[TBL] [Abstract][Full Text] [Related]
10. Immune Status and Chemokine C Receptor 7 Expression in Primary in Patients with Immune Thrombocytopenia.
Zhang L; Zhou GZ; Feng WY; Li D
Turk J Haematol; 2022 Feb; 39(1):29-37. PubMed ID: 34445858
[TBL] [Abstract][Full Text] [Related]
11. Lymphocyte subsets in primary immune thrombocytopenia.
Rong W; Yan-xiang Z; Shan-shan X; Ju-mei S
Blood Coagul Fibrinolysis; 2014 Dec; 25(8):816-9. PubMed ID: 24911458
[TBL] [Abstract][Full Text] [Related]
12. [Idiopathic thrombocytopenic purpura in children].
Gebauer E; Vijatov G
Med Pregl; 1998; 51(3-4):127-34. PubMed ID: 9611955
[TBL] [Abstract][Full Text] [Related]
13. [A study of immunocyte subsets and serum cytokine profiles before and after immunal suppression treatment in patients with immune thrombocytopenia].
Li W; Wang X; Li J; Liu M; Feng J
Zhonghua Nei Ke Za Zhi; 2016 Feb; 55(2):111-5. PubMed ID: 26875579
[TBL] [Abstract][Full Text] [Related]
14. Platelet autoantibodies in the bone marrow of patients with immune thrombocytopenia.
Shrestha S; Nazy I; Smith JW; Kelton JG; Arnold DM
Blood Adv; 2020 Jul; 4(13):2962-2966. PubMed ID: 32603421
[TBL] [Abstract][Full Text] [Related]
15. Platelet-associated antibodies, cellular immunity and FCGR3a genotype influence the response to rituximab in immune thrombocytopenia.
Cooper N; Stasi R; Cunningham-Rundles S; Cesarman E; McFarland JG; Bussel JB
Br J Haematol; 2012 Aug; 158(4):539-47. PubMed ID: 22775462
[TBL] [Abstract][Full Text] [Related]
16. [Quantities and function of NK cells in patients with immune thrombocytopenia].
Zhang YJ; Qu W; Liu H; Wang YH; Liu CY; Li LJ; Wang HQ; Fu R; Xing LM; Shao ZH
Zhonghua Yi Xue Za Zhi; 2017 Apr; 97(16):1231-1235. PubMed ID: 28441851
[No Abstract] [Full Text] [Related]
17. Biological stratification of clinical disease courses in childhood immune thrombocytopenia.
Schmidt DE; Heitink-Pollé KMJ; Mertens B; Porcelijn L; Kapur R; van der Schoot CE; Vidarsson G; van der Bom JG; Bruin MCA; de Haas M
J Thromb Haemost; 2021 Apr; 19(4):1071-1081. PubMed ID: 33386662
[TBL] [Abstract][Full Text] [Related]
18. Significance of lymphocyte counts at diagnosis in the management of ITP: the relationship between lymphocyte counts and treatment success in H. pylori-infected patients.
Nagata A; Sekiguchi N; Kurimoto M; Noto S; Takezako N
Int J Hematol; 2015 Mar; 101(3):268-72. PubMed ID: 25628102
[TBL] [Abstract][Full Text] [Related]
19. The aberrant expression of microRNAs and correlations with T cell subsets in patients with immune thrombocytopenia.
Liu L; Hua M; Liu C; He N; Li Z; Ma D
Oncotarget; 2016 Nov; 7(47):76453-76463. PubMed ID: 27802180
[TBL] [Abstract][Full Text] [Related]
20. High-dose dexamethasone or all-trans-retinoic acid restores the balance of macrophages towards M2 in immune thrombocytopenia.
Feng Q; Xu M; Yu YY; Hou Y; Mi X; Sun YX; Ma S; Zuo XY; Shao LL; Hou M; Zhang XH; Peng J
J Thromb Haemost; 2017 Sep; 15(9):1845-1858. PubMed ID: 28682499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
